Funding Opportunities: Addressing Structural Racism and Discrimination

0 comments

UPDATE: The funding opportunity, Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 Clinical Trial Optional) (RFA-MD-21-004), is now available. A pre-application technical assistance workshop will be held on May 26, 1-2:30 p.m. ET. See NOT-MD-21-018 for details.

We want to make you aware of two funding opportunities to investigate and address structural racism and discrimination in the biomedical research enterprise. This is a follow-up to our previous post about NIGMS’ support for UNITE, the trans-NIH initiative to address structural racism and promote diversity, equity, and inclusion in biomedical research.

Continue reading “Funding Opportunities: Addressing Structural Racism and Discrimination”

Webinar: Navigating Research Collaborations as a Teaching-Based Professor

6 comments

UPDATE: The video from this webinar is now available.

NIGMS is committed to increasing biomedical research capacity, including at institutions where faculty have significant teaching responsibilities. In these settings, research collaborations across institutions can be especially beneficial. Join us as we explore this topic:

Thursday, March 25, 3:00-4:00 p.m. ET

Continue reading “Webinar: Navigating Research Collaborations as a Teaching-Based Professor”

Wanted: NIGMS Deputy Director

0 comments

The search is underway for a critically important position on the NIGMS leadership team: our deputy director. The deputy director assists me in managing the Institute, advises on a range of topics, and handles special projects. This person also works closely with groups within and outside NIH and represents us on various federal and nonfederal scientific and professional committees.

Continue reading “Wanted: NIGMS Deputy Director”

NIGMS Supports UNITE, the NIH-Wide Initiative to Promote Diversity, Equity, and Inclusion in Biomedical Research

0 comments
UNITE logo. UNITE is an NIH initiative to promote diversity, equity, and inclusion in biomedical research.

On March 1, NIH Director Francis Collins announced UNITE, a new effort to end structural racism and racial inequities in the biomedical research enterprise. NIGMS fully supports this initiative and is actively reviewing our own policies, practices, procedures, and priorities. We’re also intensifying our current efforts to undo the impacts of structural racism and all other forms of structural bias and discrimination in the biomedical research enterprise. Upcoming NIGMS communications and activities will identify structural and cultural elements in biomedical research that are contributing to racism and what we’re currently doing and plan to do to address them. New initiatives include, but are not limited to:

Continue reading “NIGMS Supports UNITE, the NIH-Wide Initiative to Promote Diversity, Equity, and Inclusion in Biomedical Research”

Funding Opportunities: Urgent Competitive Revisions to NIGMS IDeA and NARCH Programs to Address SARS-CoV-2 Vaccine Hesitancy

0 comments

We’re pleased to announce the availability of supplements to active INBRE (P20), COBRE (P20, P30), IDeA-CTR (U54), and NARCH (S06) awards to support vaccine hesitancy research relevant to SARS-CoV-2. The supplements are aimed at studying the causes of SARS-CoV-2 vaccine hesitancy in IDeA states and/or American Indian/Alaska Native communities, and at developing innovative evidence-based interventions to enhance vaccine acceptance with the goal of increased vaccine uptake.

Applications are due by April 30, 2021; see NOT-GM-21-021 for additional details.

If you have any questions about this supplement opportunity, please contact me.

Equipment Funding Opportunities for NIGMS Research

0 comments

NIGMS recognizes the need to provide support to grantees for equipment, particularly to replace essential instrumentation that breaks down, or to expand into rapidly growing research areas. As an example, advances in cryo-electron microscopy (cryo-EM) detectors, microscopes, and methods have made acquisition of atomic resolution structural data a reality, and investigators need these to prepare viable specimens and process data in their home labs to successfully utilize cryo-EM data collection resources elsewhere.

We’re pleased to share with you recent funding opportunities for equipment support.

Continue reading “Equipment Funding Opportunities for NIGMS Research”

NIGMS Administrative Supplements to Support Undergraduate Summer Research

0 comments

We’re offering administrative supplements to provide summer research experiences for undergraduate students. The research experiences can be conducted remotely or in person, depending on the institutional regulations. These supplements are open to all NIGMS-funded investigators with active R01, R35, and R37 awards, including those in their final year of funding. We’ll accept requests under PA-20-272, Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional).

Continue reading “NIGMS Administrative Supplements to Support Undergraduate Summer Research”

Administrative Supplements for NIGMS Training, Research Education, and Career Development Grants to Develop Curricular, Training, and Evaluation Activities

0 comments

To continue our efforts to catalyze the modernization of biomedical research training and career development, we invite eligible institutions with NIGMS training (T32, T34), certain research education (R25), or institutional career development (K12) awards to apply for administrative supplements to develop and implement curricular, training, or administrative activities to:

Continue reading “Administrative Supplements for NIGMS Training, Research Education, and Career Development Grants to Develop Curricular, Training, and Evaluation Activities”

Funding Opportunities: Urgent Competitive Revisions to IDeA and NARCH Programs for SARS-CoV-2 Surveillance Studies

0 comments

UPDATE: The slides [PDF] and video from this webinar are now available.

We’re pleased to announce the availability of supplements to active INBRE (P20), COBRE (P20, P30), IDeA-CTR (U54), and NARCH (S06) awards for sequencing-based surveillance studies of the SARS-CoV-2 virus to track variants circulating in communities the IDeA and NARCH programs serve. The supplements will support SARS-CoV-2 viral genome sequencing and analysis studies. Projects are expected to expand on or collaborate with ongoing SARS-CoV-2 testing studies or programs in order to leverage resources and deliver results quickly to help address the urgent challenge.

Applications are due by March 31, 2021; see NOT-GM-21-031 for additional details.

If you have any questions about this supplement opportunity, please contact me.